CN113952364A - 一种外用消炎制剂 - Google Patents
一种外用消炎制剂 Download PDFInfo
- Publication number
- CN113952364A CN113952364A CN202111264423.0A CN202111264423A CN113952364A CN 113952364 A CN113952364 A CN 113952364A CN 202111264423 A CN202111264423 A CN 202111264423A CN 113952364 A CN113952364 A CN 113952364A
- Authority
- CN
- China
- Prior art keywords
- raw materials
- medicine
- parts
- external anti
- calomel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 206010061218 Inflammation Diseases 0.000 title abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 229940075397 calomel Drugs 0.000 claims abstract description 14
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 claims abstract description 14
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract description 12
- 239000010699 lard oil Substances 0.000 claims description 4
- 239000003814 drug Substances 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 10
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 208000004210 Pressure Ulcer Diseases 0.000 abstract description 3
- 208000025865 Ulcer Diseases 0.000 abstract description 3
- 230000003179 granulation Effects 0.000 abstract description 3
- 238000005469 granulation Methods 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 206010003399 Arthropod bite Diseases 0.000 abstract description 2
- 206010016228 Fasciitis Diseases 0.000 abstract description 2
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 2
- 208000026935 allergic disease Diseases 0.000 abstract description 2
- 230000007815 allergy Effects 0.000 abstract description 2
- 238000002266 amputation Methods 0.000 abstract description 2
- 210000000988 bone and bone Anatomy 0.000 abstract description 2
- 230000035876 healing Effects 0.000 abstract description 2
- 208000014674 injury Diseases 0.000 abstract description 2
- 230000007794 irritation Effects 0.000 abstract description 2
- 230000001954 sterilising effect Effects 0.000 abstract description 2
- 230000008736 traumatic injury Effects 0.000 abstract description 2
- 230000036269 ulceration Effects 0.000 abstract description 2
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 206010056340 Diabetic ulcer Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Insects & Arthropods (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Animal Husbandry (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明提供了一种外用消炎制剂，包括如下重量份配比的原料：白蜡烛400‑500、腊猪油900‑1000、陈头发2.5‑5、轻粉50‑52。本发明具有拔毒生肌，杀菌消炎、敛疮排脓的功效；使用方便，原材料易购，制药简单，价格低廉，患者容易接受；可自行换药，无任何毒副作用，无刺激性，无过敏；用于治疗跌打损伤脓疮、连骨疮、筋膜炎、蚊虫叮咬引起的发炎，尤其适合糖尿病引起的手足溃烂、褥疮，显著降低患者的截肢率，治后不复发，使患者从根本上治愈。
Description
技术领域
本发明涉及一种中药技术领域，更具体地说，涉及一种外用消炎制剂。
背景技术
随着社会生活节奏的加快和饮食结构的改变以及遗传等因素，糖尿病的发病率逐年升高，伴随而来的糖尿病溃烂、褥疮等更是普遍。糖尿病溃烂，还没有特效药物，对糖尿病后期坏死组织覆盖、渗出、破溃，甚至局部坏死，医院采取截断治疗。西医治疗这种并发症，通常采用消毒和常规换药，常见的消毒制剂主要包括医用酒精、碘酒和红花油等。这些制剂的主要作用是表层杀菌，而对于创伤内部的消炎、溃疡、感染作用并不明显，也发挥不了治疗的功效。中药治疗可治本，去病强身，且无毒副作用，广受人们接受。但是目前，一般的中药膏药虽然有一定的疗效，但适用范围窄、见效慢。
发明内容
本发明所要解决的技术问题是针对现有技术的不足，提供一种制备简单、成本低廉的外用消炎制剂，具体方案如下：
本发明是一种外用消炎制剂，其特点是，包括如下重量份配比的原料：白蜡烛400-500、腊猪油900-1000、陈头发2.5-5、轻粉50-52。
本发明所要解决的技术问题还可以通过以下的技术方案来实现的，包括如下重量份配比的原料：白蜡烛490、腊猪油950、陈头发5、轻粉51。
本发明所要解决的技术问题还可以通过以下的技术方案来实现的，包括如下重量份配比的原料：白蜡烛400、腊猪油900、陈头发2.5、轻粉50。
本发明所要解决的技术问题还可以通过以下的技术方案来实现的，包括如下重量份配比的原料：白蜡烛500、腊猪油1000、陈头发5、轻粉52。
与现有技术相比，本发明的有益效果为：具有拔毒生肌，杀菌消炎、敛疮排脓的功效；使用方便，原材料易购，制药简单，价格低廉，患者容易接受；可自行换药，无任何毒副作用，无刺激性，无过敏；用于治疗跌打损伤脓疮、连骨疮、筋膜炎、蚊虫叮咬引起的发炎，尤其适合糖尿病引起的手足溃烂、褥疮，显著降低患者的截肢率，治后不复发，使患者从根本上治愈。
具体实施方式
下面对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例1，一种外用消炎制剂，包括如下重量份配比的原料：白蜡烛400-500g、腊猪油900-1000g、陈头发2.5-5g、轻粉50-52g。白蜡烛起到平衡药量的作用；腊猪油里含有的高蛋白起到抑制伤口扩大的作用；陈头发起到拔毒消肿的作用；轻粉主要起到拔毒长肉，治疗皮肤溃疡、流脓出血的作用。
实施例2，根据实施例1所述的一种外用消炎制剂中，包括如下重量份配比的原料：白蜡烛490g、腊猪油950g、陈头发5g、轻粉51g。
实施例3，根据实施例1或2所述的一种外用消炎制剂中，包括如下重量份配比的原料：白蜡烛400g、腊猪油900g、陈头发2.5g、轻粉50g。
实施例4，根据实施例1-3所述的一种外用消炎制剂中，包括如下重量份配比的原料：白蜡烛500g、腊猪油1000g、陈头发5g、轻粉52g。
以上所述，仅为本发明专利优选的实施例，但本发明专利的保护范围并不局限于此，任何熟悉本技术领域的技术人员在本发明专利所公开的范围内，根据本发明专利的技术方案及其发明专利构思加以等同替换或改变，都属于本发明专利的保护范围。
Claims (4)
1.一种外用消炎制剂，其特征在于，包括如下重量份配比的原料：白蜡烛400-500、腊猪油900-1000、陈头发2.5-5、轻粉50-52。
2.根据权利要求1所述的一种外用消炎制剂，其特征在于，包括如下重量份配比的原料：白蜡烛490、腊猪油950、陈头发5、轻粉51。
3.根据权利要求1所述的一种外用消炎制剂，其特征在于，包括如下重量份配比的原料：白蜡烛400、腊猪油900、陈头发2.5、轻粉50。
4.根据权利要求1所述的一种外用消炎制剂，其特征在于，包括如下重量份配比的原料：白蜡烛500、腊猪油1000、陈头发5、轻粉52。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111264423.0A CN113952364A (zh) | 2021-10-28 | 2021-10-28 | 一种外用消炎制剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111264423.0A CN113952364A (zh) | 2021-10-28 | 2021-10-28 | 一种外用消炎制剂 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113952364A true CN113952364A (zh) | 2022-01-21 |
Family
ID=79468030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111264423.0A Pending CN113952364A (zh) | 2021-10-28 | 2021-10-28 | 一种外用消炎制剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113952364A (zh) |
-
2021
- 2021-10-28 CN CN202111264423.0A patent/CN113952364A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20140213990A1 (en) | Compositions and methods for treating surface wounds | |
| CN101428122A (zh) | 一种中药去腐生肌粉及其制备方法 | |
| CN103230493B (zh) | 一种治疗创口不愈的中药组合物 | |
| CN105535334A (zh) | 一种紫芪生肌膏及制备方法 | |
| WO2020144564A1 (en) | Composition for the treatment of skin lesions and irritations | |
| CN112618646A (zh) | 一种治疗烧伤的中药组合物、中药油及其制备方法 | |
| CN113952364A (zh) | 一种外用消炎制剂 | |
| CN100350921C (zh) | 一种去除皮肤病的药物 | |
| RU2577950C1 (ru) | Способ стимуляции заживления дермальных ожогов | |
| CN108392572B (zh) | 一种祛瘀生肌敛疮止疼的膏药及其制备方法和应用 | |
| CN108635362B (zh) | 一种治疗糖尿病足的药物组合物 | |
| CN102743587A (zh) | 一种外用创伤修复液 | |
| CN104800280A (zh) | 糖尿病手足伤口愈合中药膏及制备方法 | |
| Avijgan et al. | An innovation for retarded healing process of a chronic ulcer by Aloe vera gel treatment | |
| Balasooriya et al. | Wound healing potential of bark paste of Pongamia pinnata along with hirudotherapy: A case report | |
| CN101869578B (zh) | 拔毒消炎外用擦剂 | |
| Sari et al. | A case study of using chlorhexidine gluconate for mouth ulcer care | |
| EP3972561B1 (en) | Preparation for use in the therapeutic treatment of ulcerated skin lesions, wherein the preparation is administered topically and relative growth factor | |
| Zhang et al. | Analysis of combined therapy and treatment effect of localized ultraviolet irradiation and Shengji Yuhong cream on diabetic foot | |
| RU2462258C1 (ru) | Способ лечения ран и раневой инфекции кожи и мягких тканей | |
| Yarnell et al. | Topical applications of botanical medicine: Aloe vera and other medicinal plants for healing | |
| CN1759879A (zh) | 治疗褥疮的中药药膏及其制备方法 | |
| CN1229117C (zh) | 治疗腋臭的酒剂 | |
| CN1181247A (zh) | 一种治疗皮肤溃疡的外用中药制剂 | |
| Roos | The Use of Hypochlorous Acid in the Healing of a Diabetic Foot Ulcer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20220121 |